Gclm | Rat | (-)-demecolcine | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of GCLM mRNA | CTD | PMID:23649840 |
Gclm | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | epigallocatechin gallate results in increased expression of GCLM mRNA | CTD | PMID:25585349 |
Gclm | Rat | (E)-cinnamyl alcohol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of GCLM mRNA | CTD | PMID:20566472 more ... |
Gclm | Rat | (R)-lipoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Thioctic Acid results in increased expression of GCLM mRNA and Thioctic Acid results in increased expression of GCLM protein | CTD | PMID:16249512 and PMID:26365678 |
Gclm | Rat | (R)-lipoic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Thioctic Acid promotes the reaction [Cadmium Chloride results in increased expression of GCLM mRNA] and Thioctic Acid promotes the reaction [Cadmium Chloride results in increased expression of GCLM protein] | CTD | PMID:26365678 |
Gclm | Rat | (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of GCLM mRNA] and Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of GCLM protein] | CTD | PMID:32061141 |
Gclm | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | CTD | PMID:22389237 |
Gclm | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA | CTD | PMID:24530478 |
Gclm | Rat | (S)-colchicine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Colchicine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA] | CTD | PMID:37573684 |
Gclm | Rat | (S)-naringenin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | naringenin results in increased expression of GCLM protein | CTD | PMID:31254498 |
Gclm | Rat | (S)-naringenin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [naringenin results in increased expression of GCLM protein] | CTD | PMID:31254498 |
Gclm | Rat | 1,1'-azobis(N,N-dimethylformamide) | increases expression | EXP | | 6480464 | Diamide results in increased expression of GCLM mRNA and Diamide results in increased expression of GCLM protein | CTD | PMID:15115889 |
Gclm | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | EXP | | 6480464 | o and p'-DDT affects the expression of GCLM mRNA | CTD | PMID:17984292 |
Gclm | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | ISO | Gclm (Mus musculus) | 6480464 | o and p'-DDT affects the expression of GCLM mRNA | CTD | PMID:18925944 |
Gclm | Rat | 1,1-dichloroethene | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of GCLM mRNA | CTD | PMID:26682919 |
Gclm | Rat | 1,2-dimethylhydrazine | affects expression | ISO | Gclm (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of GCLM mRNA | CTD | PMID:22206623 |
Gclm | Rat | 1,3-benzothiazole-2-thiol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | captax results in increased expression of GCLM mRNA | CTD | PMID:23999411 and PMID:24211530 |
Gclm | Rat | 1,3-dichloropropan-2-ol | increases expression | EXP | | 6480464 | 1 and 3-dichloro-2-propanol results in increased expression of GCLM mRNA | CTD | PMID:26143167 |
Gclm | Rat | 1,4-benzoquinone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | quinone results in increased expression of GCLM protein | CTD | PMID:21059386 |
Gclm | Rat | 1,4-phenylenediamine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 4-phenylenediamine results in increased expression of GCLM mRNA | CTD | PMID:16314067 more ... |
Gclm | Rat | 1-bromopropane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLM mRNA] | CTD | PMID:20211940 |
Gclm | Rat | 1-bromopropane | increases expression | ISO | Gclm (Mus musculus) | 6480464 | 1-bromopropane results in increased expression of GCLM mRNA | CTD | PMID:20211940 |
Gclm | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of GCLM mRNA | CTD | PMID:20146380 more ... |
Gclm | Rat | 1-chloro-2,4-dinitrobenzene | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Dinitrochlorobenzene results in increased expression of GCLM mRNA] | CTD | PMID:27965148 |
Gclm | Rat | 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Dinitrofluorobenzene results in increased expression of GCLM mRNA | CTD | PMID:23999411 |
Gclm | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:31187328 |
Gclm | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GCLM mRNA | CTD | PMID:20551477 |
Gclm | Rat | 1-naphthyl isothiocyanate | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of GCLM mRNA | CTD | PMID:37348807 |
Gclm | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of GCLM protein and tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of GCLM mRNA] | CTD | PMID:37348807 |
Gclm | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of GCLM mRNA | CTD | PMID:27344345 |
Gclm | Rat | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Ethinyl Estradiol co-treated with epomediol] results in increased activity of GCLM protein | CTD | PMID:12071332 |
Gclm | Rat | 17beta-estradiol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Estradiol results in increased expression of GCLM mRNA | CTD | PMID:20106945 and PMID:31614463 |
Gclm | Rat | 17beta-estradiol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Estradiol results in increased expression of GCLM mRNA | CTD | PMID:39298647 |
Gclm | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of GCLM mRNA | CTD | PMID:32145629 |
Gclm | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of GCLM mRNA | CTD | PMID:22389237 |
Gclm | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | CTD | PMID:22389237 |
Gclm | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:38568856 |
Gclm | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [2 more ... | CTD | PMID:25305463 |
Gclm | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Gclm (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 |
Gclm | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein affects the reaction [2 more ... | CTD | PMID:25797475 |
Gclm | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:25305463 |
Gclm | Rat | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLM mRNA | CTD | PMID:18163543 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLM mRNA | CTD | PMID:33387578 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLM mRNA | CTD | PMID:11489354 more ... |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GCLM mRNA | CTD | PMID:25975270 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCLM mRNA | CTD | PMID:21570461 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCLM mRNA | CTD | PMID:22298810 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM results in decreased susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:22082335 |
Gclm | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCLM mRNA | CTD | PMID:21215274 |
Gclm | Rat | 2,3-dimethoxynaphthalene-1,4-dione | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | [GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to 2 more ... | CTD | PMID:23315585 |
Gclm | Rat | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of GCLM mRNA | CTD | PMID:22609641 |
Gclm | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Gclm (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
Gclm | Rat | 2-(chloromethyl)pyridine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-chloromethylpyridine results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLM mRNA | CTD | PMID:16158176 |
Gclm | Rat | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 8-oxoberberine promotes the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of GCLM mRNA] more ... | CTD | PMID:28887131 and PMID:35691465 |
Gclm | Rat | 2-bromo-2-(bromomethyl)pentanedinitrile | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:23999411 and PMID:27965148 |
Gclm | Rat | 2-Ethylhexyl acrylate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-ethylhexyl acrylate results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | hydroxyethyl methacrylate results in increased expression of GCLM mRNA and hydroxyethyl methacrylate results in increased expression of GCLM protein | CTD | PMID:30497689 |
Gclm | Rat | 2-hydroxypropanoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | 2-palmitoylglycerol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of GCLM mRNA | CTD | PMID:37199045 |
Gclm | Rat | 2-tert-butylhydroquinone | increases expression | ISO | Gclm (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased expression of GCLM mRNA | CTD | PMID:12007577 more ... |
Gclm | Rat | 2-tert-butylhydroquinone | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in decreased expression of GCLM mRNA | CTD | PMID:35724838 |
Gclm | Rat | 2-tert-butylhydroquinone | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] more ... | CTD | PMID:24632381 and PMID:25305463 |
Gclm | Rat | 2-tert-butylhydroquinone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in increased expression of GCLM mRNA | CTD | PMID:12081989 and PMID:25003661 |
Gclm | Rat | 2-tert-butylhydroquinone | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLM mRNA] | CTD | PMID:19328227 |
Gclm | Rat | 2-tert-butylhydroquinone | increases expression | EXP | | 6480464 | 2-tert-butylhydroquinone results in increased expression of GCLM mRNA | CTD | PMID:10978506 |
Gclm | Rat | 3,7-dihydropurine-6-thione | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Mercaptopurine results in increased expression of GCLM mRNA | CTD | PMID:18222062 |
Gclm | Rat | 3-Hydroxybenzo[a]pyrene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 3-hydroxybenzo(a)pyrene results in increased expression of GCLM mRNA | CTD | PMID:26238291 |
Gclm | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of GCLM mRNA | CTD | PMID:33412187 |
Gclm | Rat | 3-methoxycatechol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 3-methoxycatechol results in increased expression of GCLM mRNA | CTD | PMID:38598786 |
Gclm | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | CTD | PMID:20351055 |
Gclm | Rat | 3-phenylprop-2-enal | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cinnamaldehyde results in increased expression of GCLM mRNA | CTD | PMID:17178418 more ... |
Gclm | Rat | 3H-1,2-dithiole-3-thione | affects expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione affects the expression of GCLM mRNA | CTD | PMID:19162173 |
Gclm | Rat | 3H-1,2-dithiole-3-thione | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [1 and 2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | CTD | PMID:22495766 |
Gclm | Rat | 4,4'-methylene-bis-(2-chloroaniline) | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Methylenebis(chloroaniline) results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | bisphenol S results in increased expression of GCLM mRNA | CTD | PMID:39298647 |
Gclm | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bisphenol S results in increased expression of GCLM protein | CTD | PMID:34186270 |
Gclm | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Oxazolone results in increased expression of GCLM mRNA | CTD | PMID:23999411 |
Gclm | Rat | 4-hydroxy-TEMPO | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [tempol inhibits the reaction [lipopolysaccharide more ... | CTD | PMID:38454815 |
Gclm | Rat | 4-hydroxynon-2-enal | increases expression | ISO | Gclm (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of GCLM mRNA | CTD | PMID:19191707 |
Gclm | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Fenretinide results in increased expression of GCLM mRNA | CTD | PMID:28973697 |
Gclm | Rat | 4-nitro-1,2-phenylenediamine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 1 and 2-diamino-4-nitrobenzene results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | 4-nitrobenzyl bromide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 4-nitrobenzyl bromide results in increased expression of GCLM mRNA | CTD | PMID:23999411 |
Gclm | Rat | 4-phenyl-3-furoxancarbonitrile | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 4-phenyl-3-furoxancarbonitrile results in increased expression of GCLM mRNA | CTD | PMID:22851183 |
Gclm | Rat | 5-fluorouracil | affects response to substance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
Gclm | Rat | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | multiple interactions | EXP | | 6480464 | 6-chloro-2 more ... | CTD | PMID:33661552 |
Gclm | Rat | 7,8-dihydroxycoumarin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | daphnetin results in increased expression of GCLM protein | CTD | PMID:30738023 |
Gclm | Rat | 7beta-aminocephalosporanic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 7-aminocephalosporanic acid results in increased expression of GCLM mRNA | CTD | PMID:24211530 |
Gclm | Rat | [6]-Shogaol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | shogaol metabolite results in increased expression of GCLM protein and shogaol results in increased expression of GCLM protein | CTD | PMID:25148906 |
Gclm | Rat | abietic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | abietic acid results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | acetylcholine | affects response to substance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene SNP affects the susceptibility to Acetylcholine | CTD | PMID:12975258 |
Gclm | Rat | acrolein | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Acrolein results in increased expression of GCLM mRNA | CTD | PMID:12763045 |
Gclm | Rat | acrolein | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | CLDN1 protein promotes the reaction [Acrolein results in increased expression of GCLM mRNA] | CTD | PMID:38142011 |
Gclm | Rat | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of GCLM mRNA | CTD | PMID:38090360 |
Gclm | Rat | acrolein | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Acrolein results in increased expression of GCLM mRNA | CTD | PMID:24211530 |
Gclm | Rat | acrylamide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | salvin inhibits the reaction [Acrylamide results in decreased expression of GCLM mRNA] | CTD | PMID:28159594 |
Gclm | Rat | acrylamide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Acrylamide results in increased expression of GCLM mRNA | CTD | PMID:32763439 |
Gclm | Rat | acrylamide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of GCLM mRNA | CTD | PMID:28159594 |
Gclm | Rat | actinomycin D | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of GCLM protein | CTD | PMID:38460933 |
Gclm | Rat | Aescin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein] | CTD | PMID:36905866 |
Gclm | Rat | Aescin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Escin inhibits the reaction [Dietary Fats results in decreased expression of GCLM protein] and NFE2L2 protein affects the reaction [Escin inhibits the reaction [Dietary Fats results in decreased expression of GCLM protein]] | CTD | PMID:36905866 |
Gclm | Rat | Aescin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Escin results in increased expression of GCLM protein | CTD | PMID:36905866 |
Gclm | Rat | aflatoxin B1 | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of GCLM mRNA | CTD | PMID:19770486 |
Gclm | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GCLM mRNA | CTD | PMID:23630614 and PMID:25378103 |
Gclm | Rat | AL 8810 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | AL 8810 inhibits the reaction [fluprostenol promotes the reaction [Oxidopamine results in increased expression of GCLM mRNA]] | CTD | PMID:33486071 |
Gclm | Rat | alachlor | increases expression | EXP | | 6480464 | alachlor results in increased expression of GCLM protein | CTD | PMID:14563481 |
Gclm | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | aldehydo-D-glucose | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of GCLM mRNA and Tretinoin results in decreased expression of GCLM protein | CTD | PMID:30267739 |
Gclm | Rat | all-trans-retinoic acid | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GCLM mRNA | CTD | PMID:33167477 |
Gclm | Rat | all-trans-retinoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GCLM mRNA | CTD | PMID:38040126 |
Gclm | Rat | alpha,alpha-trehalose | multiple interactions | EXP | | 6480464 | Trehalose inhibits the reaction [cadmium acetate results in increased expression of GCLM protein] | CTD | PMID:29140578 |
Gclm | Rat | alpha-hexylcinnamaldehyde | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | hexyl cinnamic aldehyde results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | alpha-Solamarine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of GCLM mRNA] | CTD | PMID:35350913 |
Gclm | Rat | aminoguanidine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | pimagedine inhibits the reaction [Spermidine results in increased expression of GCLM mRNA] | CTD | PMID:12763045 |
Gclm | Rat | amiodarone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Amiodarone results in increased expression of GCLM mRNA | CTD | PMID:36586010 |
Gclm | Rat | amlexanox | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLM mRNA | CTD | PMID:31697998 |
Gclm | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GCLM mRNA | CTD | PMID:16483693 |
Gclm | Rat | ammonium hexachloroplatinate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | ammonium hexachloroplatinate results in increased expression of GCLM mRNA | CTD | PMID:24211530 |
Gclm | Rat | ampicillin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ampicillin results in increased expression of GCLM mRNA | CTD | PMID:22609641 |
Gclm | Rat | ampicillin | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ampicillin results in decreased expression of GCLM mRNA | CTD | PMID:21632981 |
Gclm | Rat | andrographolide | increases expression | EXP | | 6480464 | andrographolide results in increased expression of GCLM mRNA and andrographolide results in increased expression of GCLM protein | CTD | PMID:25110055 and PMID:29355602 |
Gclm | Rat | andrographolide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [andrographolide co-treated with TNF protein] results in increased expression of GCLM mRNA | CTD | PMID:35724838 |
Gclm | Rat | andrographolide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | andrographolide results in decreased expression of GCLM mRNA | CTD | PMID:35724838 |
Gclm | Rat | andrographolide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | andrographolide results in increased expression of GCLM protein | CTD | PMID:29355602 |
Gclm | Rat | andrographolide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | andrographolide results in increased expression of GCLM protein | CTD | PMID:29355602 |
Gclm | Rat | andrographolide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA and andrographolide inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] | CTD | PMID:19737545 and PMID:29355602 |
Gclm | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [[Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA] more ... | CTD | PMID:25881548 |
Gclm | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | decreases activity | ISO | GCLM (Homo sapiens) | 6480464 | pyrazolanthrone results in decreased activity of GCLM protein | CTD | PMID:16972261 |
Gclm | Rat | antimonite | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA | CTD | PMID:32076005 |
Gclm | Rat | antimycin A | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Antimycin A results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | antirheumatic drug | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of GCLM mRNA | CTD | PMID:24449571 |
Gclm | Rat | apigenin | increases expression | EXP | | 6480464 | Apigenin results in increased expression of GCLM mRNA and Apigenin results in increased expression of GCLM protein | CTD | PMID:22864849 |
Gclm | Rat | apigenin | multiple interactions | EXP | | 6480464 | [Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:22864849 |
Gclm | Rat | arachidonic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arachidonic Acid results in increased expression of GCLM mRNA | CTD | PMID:16704987 |
Gclm | Rat | arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid metabolite results in increased expression of GCLM mRNA | CTD | PMID:27012417 |
Gclm | Rat | aristolochic acid A | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of GCLM mRNA | CTD | PMID:33212167 |
Gclm | Rat | arotinoid acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gclm | Rat | arsane | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic results in increased expression of GCLM mRNA and Arsenic results in increased expression of GCLM protein | CTD | PMID:18487201 more ... |
Gclm | Rat | arsane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Arsenic results in increased expression of GCLM protein] | CTD | PMID:35523338 |
Gclm | Rat | arsane | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Arsenic results in increased expression of GCLM protein | CTD | PMID:35523338 |
Gclm | Rat | arsane | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCLM mRNA more ... | CTD | PMID:32188015 more ... |
Gclm | Rat | arsenic atom | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic results in increased expression of GCLM mRNA and Arsenic results in increased expression of GCLM protein | CTD | PMID:18487201 more ... |
Gclm | Rat | arsenic atom | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Arsenic results in increased expression of GCLM protein | CTD | PMID:35523338 |
Gclm | Rat | arsenic atom | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Arsenic results in increased expression of GCLM protein] | CTD | PMID:35523338 |
Gclm | Rat | arsenic atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCLM mRNA more ... | CTD | PMID:32188015 more ... |
Gclm | Rat | arsenite(3-) | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | arsenite results in increased expression of GCLM mRNA | CTD | PMID:22476201 and PMID:25680285 |
Gclm | Rat | arsenite(3-) | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GCLM mRNA more ... | CTD | PMID:22476201 more ... |
Gclm | Rat | arsenite(3-) | increases expression | ISO | Gclm (Mus musculus) | 6480464 | arsenite results in increased expression of GCLM mRNA and arsenite results in increased expression of GCLM protein | CTD | PMID:15894712 more ... |
Gclm | Rat | arsenite(3-) | increases stability | ISO | Gclm (Mus musculus) | 6480464 | arsenite results in increased stability of GCLM mRNA | CTD | PMID:19328227 |
Gclm | Rat | arsenite(3-) | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arsenite results in increased expression of GCLM mRNA] more ... | CTD | PMID:15894712 more ... |
Gclm | Rat | arsenous acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GCLM mRNA | CTD | PMID:15725085 more ... |
Gclm | Rat | arsenous acid | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of GCLM protein | CTD | PMID:25341331 |
Gclm | Rat | arsenous acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLM mRNA more ... | CTD | PMID:19350554 more ... |
Gclm | Rat | artesunate | decreases response to substance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM mRNA results in decreased susceptibility to artesunate | CTD | PMID:15796179 |
Gclm | Rat | astilbin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | astilbin promotes the reaction [Cisplatin results in increased expression of GCLM mRNA] | CTD | PMID:29471006 |
Gclm | Rat | atrazine | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Atrazine results in increased expression of GCLM mRNA | CTD | PMID:36216167 |
Gclm | Rat | atrazine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of GCLM mRNA] | CTD | PMID:36216167 |
Gclm | Rat | Augmentin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA | CTD | PMID:34767876 |
Gclm | Rat | azathioprine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Azathioprine results in increased expression of GCLM mRNA | CTD | PMID:18222062 more ... |
Gclm | Rat | Azoxymethane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLM mRNA | CTD | PMID:29950665 |
Gclm | Rat | azoxystrobin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | azoxystrobin results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | Bandrowski's base | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Bandrowski's base results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | Bardoxolone methyl | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bardoxolone methyl results in increased expression of GCLM and bardoxolone methyl results in increased expression of GCLM mRNA | CTD | PMID:21723306 and PMID:34480604 |
Gclm | Rat | Bardoxolone methyl | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | bardoxolone methyl results in decreased expression of GCLM mRNA | CTD | PMID:35724838 |
Gclm | Rat | benfotiamine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA] and NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GCLM mRNA] | CTD | PMID:29860433 |
Gclm | Rat | benfotiamine | increases expression | ISO | Gclm (Mus musculus) | 6480464 | benphothiamine metabolite results in increased expression of GCLM mRNA and benphothiamine results in increased expression of GCLM mRNA | CTD | PMID:29860433 |
Gclm | Rat | benzalkonium chloride | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Benzalkonium Compounds results in increased expression of GCLM mRNA | CTD | PMID:30806763 |
Gclm | Rat | benzene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Benzene results in increased expression of GCLM mRNA | CTD | PMID:21843810 |
Gclm | Rat | benzidine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | benzidine results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | benzo[a]pyrene | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GCLM mRNA more ... | CTD | PMID:15894712 more ... |
Gclm | Rat | benzo[a]pyrene | affects methylation | ISO | GCLM (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GCLM promoter | CTD | PMID:27901495 |
Gclm | Rat | benzo[a]pyrene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GCLM mRNA and Benzo(a)pyrene results in increased expression of GCLM protein | CTD | PMID:20064835 more ... |
Gclm | Rat | benzo[a]pyrene | increases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:23135907 and PMID:28279692 |
Gclm | Rat | benzo[a]pyrene | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form results in decreased susceptibility to Benzo(a)pyrene | CTD | PMID:24291350 |
Gclm | Rat | benzo[a]pyrene | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GCLM mRNA | CTD | PMID:15034205 more ... |
Gclm | Rat | benzo[a]pyrene | affects response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:22253057 |
Gclm | Rat | benzo[a]pyrene | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of GCLM mRNA | CTD | PMID:22228805 |
Gclm | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 |
Gclm | Rat | benzoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Benzoic Acid results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | benzoquinones | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Benzoquinones analog results in increased expression of GCLM protein | CTD | PMID:21651925 |
Gclm | Rat | benzylpenicillin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Penicillin G results in increased expression of GCLM mRNA | CTD | PMID:22609641 |
Gclm | Rat | berberine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Bortezomib results in increased expression of GCLM mRNA] | CTD | PMID:35121005 |
Gclm | Rat | beta-lapachone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of GCLM mRNA | CTD | PMID:38218311 |
Gclm | Rat | beta-naphthoflavone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of GCLM mRNA | CTD | PMID:19737606 and PMID:32858204 |
Gclm | Rat | beta-naphthoflavone | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA | CTD | PMID:19737545 |
Gclm | Rat | beta-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | CTD | PMID:22389237 |
Gclm | Rat | Betanin | multiple interactions | EXP | | 6480464 | 6-chloro-2 more ... | CTD | PMID:33661552 |
Gclm | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of GCLM mRNA and Diethylhexyl Phthalate results in increased expression of GCLM protein | CTD | PMID:34319233 more ... |
Gclm | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of GCLM mRNA | CTD | PMID:33754040 and PMID:36696656 |
Gclm | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GCLM mRNA] | CTD | PMID:35917956 |
Gclm | Rat | bisdemethoxycurcumin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | bisdemethoxycurcumin results in increased expression of GCLM mRNA | CTD | PMID:17535857 |
Gclm | Rat | bisdemethoxycurcumin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bisdemethoxycurcumin results in increased expression of GCLM mRNA and bisdemethoxycurcumin results in increased expression of GCLM protein | CTD | PMID:19188863 |
Gclm | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GCLM mRNA | CTD | PMID:25181051 more ... |
Gclm | Rat | bisphenol A | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:39117098 |
Gclm | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GCLM mRNA | CTD | PMID:32145629 |
Gclm | Rat | bisphenol A | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | bisphenol A affects the expression of GCLM mRNA | CTD | PMID:30903817 |
Gclm | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of GCLM gene | CTD | PMID:28505145 |
Gclm | Rat | bisphenol A | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GCLM mRNA | CTD | PMID:26063408 and PMID:39117098 |
Gclm | Rat | Bisphenol A diglycidyl ether | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bisphenol A diglycidyl ether results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | Bisphenol A glycidylmethacrylate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Bisphenol A-Glycidyl Methacrylate results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | bisphenol AF | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of GCLM protein | CTD | PMID:34186270 |
Gclm | Rat | bisphenol F | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bisphenol F results in increased expression of GCLM protein | CTD | PMID:34186270 |
Gclm | Rat | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of GCLM mRNA | CTD | PMID:35121005 |
Gclm | Rat | bortezomib | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Bortezomib results in increased expression of GCLM mRNA] | CTD | PMID:35121005 |
Gclm | Rat | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of GCLM mRNA | CTD | PMID:12628495 |
Gclm | Rat | buta-1,3-diene | increases expression | ISO | Gclm (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of GCLM mRNA | CTD | PMID:29038090 |
Gclm | Rat | butan-1-ol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GCLM mRNA | CTD | PMID:29432896 |
Gclm | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of GCLM mRNA | CTD | PMID:19167457 |
Gclm | Rat | cadmium acetate | increases expression | EXP | | 6480464 | cadmium acetate results in increased expression of GCLM protein | CTD | PMID:29140578 |
Gclm | Rat | cadmium acetate | multiple interactions | EXP | | 6480464 | Trehalose inhibits the reaction [cadmium acetate results in increased expression of GCLM protein] | CTD | PMID:29140578 |
Gclm | Rat | cadmium atom | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Cadmium results in increased expression of GCLM mRNA | CTD | PMID:21120746 more ... |
Gclm | Rat | cadmium atom | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Cadmium results in decreased expression of GCLM mRNA | CTD | PMID:37270049 |
Gclm | Rat | cadmium atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCLM mRNA | CTD | PMID:35301059 |
Gclm | Rat | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of GCLM mRNA | CTD | PMID:25388156 |
Gclm | Rat | cadmium atom | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCLM mRNA more ... | CTD | PMID:33398418 |
Gclm | Rat | cadmium dichloride | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of GCLM mRNA | CTD | PMID:20061341 |
Gclm | Rat | cadmium dichloride | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCLM mRNA more ... | CTD | PMID:26365678 more ... |
Gclm | Rat | cadmium dichloride | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of GCLM mRNA and Cadmium Chloride results in increased expression of GCLM protein | CTD | PMID:25596134 more ... |
Gclm | Rat | cadmium dichloride | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCLM mRNA more ... | CTD | PMID:26827822 and PMID:33398418 |
Gclm | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of GCLM mRNA | CTD | PMID:19010381 |
Gclm | Rat | cannabidiol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Cannabidiol results in increased expression of GCLM mRNA | CTD | PMID:21542829 |
Gclm | Rat | cannabidiol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of GCLM mRNA | CTD | PMID:31518892 |
Gclm | Rat | captan | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Captan results in increased expression of GCLM mRNA | CTD | PMID:31558096 |
Gclm | Rat | carbamazepine | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GCLM mRNA | CTD | PMID:24752500 and PMID:25979313 |
Gclm | Rat | carbaryl | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Carbaryl results in increased expression of GCLM mRNA | CTD | PMID:27829164 |
Gclm | Rat | carbon nanotube | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Nanotubes and Carbon results in increased expression of GCLM protein | CTD | PMID:23026733 |
Gclm | Rat | carnosic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GCLM protein] more ... | CTD | PMID:25446857 more ... |
Gclm | Rat | carnosic acid | multiple interactions | EXP | | 6480464 | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLM protein] | CTD | PMID:25446857 |
Gclm | Rat | carnosic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | salvin results in increased expression of GCLM protein | CTD | PMID:26577515 and PMID:26686574 |
Gclm | Rat | Carnosol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | carnosol results in increased expression of GCLM mRNA | CTD | PMID:20116392 |
Gclm | Rat | celastrol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | celastrol results in increased expression of GCLM mRNA | CTD | PMID:17010675 |
Gclm | Rat | celastrol | multiple interactions | EXP | | 6480464 | celastrol inhibits the reaction [Doxorubicin results in decreased expression of GCLM mRNA] | CTD | PMID:30588110 |
Gclm | Rat | ceric oxide | decreases expression | EXP | | 6480464 | ceric oxide results in decreased expression of GCLM mRNA | CTD | PMID:29463257 |
Gclm | Rat | cerium trichloride | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | cerous chloride results in decreased expression of GCLM mRNA | CTD | PMID:28954213 |
Gclm | Rat | chalcone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Chalcone analog results in increased expression of GCLM mRNA and Chalcone analog results in increased expression of GCLM protein | CTD | PMID:31299238 |
Gclm | Rat | chenodeoxycholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Chenodeoxycholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione more ... | CTD | PMID:17724089 and PMID:33819548 |
Gclm | Rat | chenodeoxycholic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Chenodeoxycholic Acid results in increased expression of GCLM protein | CTD | PMID:17724089 |
Gclm | Rat | CHIR 99021 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gclm | Rat | chlorambucil | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Chlorambucil | CTD | PMID:10900222 |
Gclm | Rat | chloroacetaldehyde | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | chlorogenic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Chlorogenic Acid results in increased expression of GCLM mRNA | CTD | PMID:29136249 |
Gclm | Rat | chloropicrin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | chloropicrin results in increased expression of GCLM mRNA | CTD | PMID:24211530 |
Gclm | Rat | chloroprene | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Chloroprene results in increased expression of GCLM mRNA | CTD | PMID:23125180 |
Gclm | Rat | chlorpyrifos | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Hydrogen inhibits the reaction [Chlorpyrifos results in decreased expression of GCLM mRNA] | CTD | PMID:32955216 |
Gclm | Rat | chlorpyrifos | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of GCLM mRNA | CTD | PMID:32955216 |
Gclm | Rat | choline | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GCLM mRNA | CTD | PMID:20938992 |
Gclm | Rat | chromium(6+) | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GCLM mRNA | CTD | PMID:25820237 |
Gclm | Rat | chrysin | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] more ... | CTD | PMID:22864849 and PMID:33121995 |
Gclm | Rat | chrysin | increases expression | EXP | | 6480464 | chrysin results in increased expression of GCLM mRNA and chrysin results in increased expression of GCLM protein | CTD | PMID:22864849 |
Gclm | Rat | cidofovir anhydrous | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Cidofovir results in increased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | cinnamyl alcohol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of GCLM mRNA | CTD | PMID:20566472 more ... |
Gclm | Rat | cisplatin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | astilbin promotes the reaction [Cisplatin results in increased expression of GCLM mRNA] more ... | CTD | PMID:17628013 more ... |
Gclm | Rat | cisplatin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GCLM mRNA | CTD | PMID:25450742 more ... |
Gclm | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of GCLM mRNA | CTD | PMID:33661552 |
Gclm | Rat | cisplatin | multiple interactions | EXP | | 6480464 | 6-chloro-2 more ... | CTD | PMID:33661552 |
Gclm | Rat | citraconic acid | increases expression | EXP | | 6480464 | citraconic acid results in increased expression of GCLM protein | CTD | PMID:27277809 |
Gclm | Rat | citraconic acid | increases expression | ISO | Gclm (Mus musculus) | 6480464 | citraconic acid results in increased expression of GCLM mRNA | CTD | PMID:27277809 |
Gclm | Rat | citral | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | citral results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | clavulanic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Clavulanic Acid results in increased expression of GCLM mRNA | CTD | PMID:34767876 |
Gclm | Rat | Clivoline | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | clivorine results in decreased expression of GCLM mRNA | CTD | PMID:25881548 |
Gclm | Rat | Clivoline | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA]] and Quercetin inhibits the reaction [clivorine results in decreased expression of GCLM mRNA] | CTD | PMID:25881548 |
Gclm | Rat | clodronic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Clodronic Acid results in increased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of GCLM protein | CTD | PMID:16470657 |
Gclm | Rat | cobalt atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of GCLM mRNA | CTD | PMID:23052192 |
Gclm | Rat | cobalt dichloride | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of GCLM mRNA | CTD | PMID:19320972 more ... |
Gclm | Rat | cobalt dichloride | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | KEAP1 protein inhibits the reaction [cobaltous chloride results in increased expression of GCLM mRNA] and NFE2L2 protein promotes the reaction [cobaltous chloride results in increased expression of GCLM mRNA] | CTD | PMID:29966676 |
Gclm | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of GCLM mRNA and cobaltous chloride results in increased expression of GCLM protein | CTD | PMID:24386269 |
Gclm | Rat | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of GCLM mRNA | CTD | PMID:20187946 |
Gclm | Rat | cocaine | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Cocaine results in increased expression of GCLM mRNA | CTD | PMID:30393195 |
Gclm | Rat | cocaine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | PRKCD protein affects the reaction [Cocaine results in increased expression of GCLM mRNA] and rottlerin promotes the reaction [Cocaine results in increased expression of GCLM mRNA] | CTD | PMID:30393195 |
Gclm | Rat | coniferyl aldehyde | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | coniferaldehyde results in increased expression of GCLM mRNA | CTD | PMID:26275128 |
Gclm | Rat | copper atom | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Copper analog results in increased expression of GCLM protein and Copper results in increased expression of GCLM protein | CTD | PMID:23882024 |
Gclm | Rat | copper atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of GCLM mRNA more ... | CTD | PMID:20971185 more ... |
Gclm | Rat | copper(0) | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Copper analog results in increased expression of GCLM protein and Copper results in increased expression of GCLM protein | CTD | PMID:23882024 |
Gclm | Rat | copper(0) | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of GCLM mRNA more ... | CTD | PMID:20971185 more ... |
Gclm | Rat | copper(II) chloride | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cupric chloride results in increased expression of GCLM mRNA | CTD | PMID:17211630 more ... |
Gclm | Rat | copper(II) sulfate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of GCLM mRNA | CTD | PMID:19549813 |
Gclm | Rat | cortisol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gclm | Rat | coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of GCLM mRNA | CTD | PMID:18480146 |
Gclm | Rat | coumestrol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA | CTD | PMID:19167446 |
Gclm | Rat | crocidolite asbestos | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos more ... | CTD | PMID:15520183 |
Gclm | Rat | crocidolite asbestos | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of GCLM mRNA | CTD | PMID:15520183 |
Gclm | Rat | CU-O LINKAGE | increases expression | ISO | Gclm (Mus musculus) | 6480464 | cupric oxide analog results in increased expression of GCLM protein | CTD | PMID:23882024 |
Gclm | Rat | CU-O LINKAGE | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cupric oxide results in increased expression of GCLM mRNA | CTD | PMID:24343273 |
Gclm | Rat | cumene hydroperoxide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | cumene hydroperoxide results in increased expression of GCLM mRNA | CTD | PMID:30547568 |
Gclm | Rat | curcumin | multiple interactions | EXP | | 6480464 | Curcumin results in increased activity of [GCLC protein binds to GCLM protein] | CTD | PMID:17602960 |
Gclm | Rat | curcumin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Curcumin promotes the reaction [sodium arsenite results in increased expression of GCLM mRNA] | CTD | PMID:34272803 |
Gclm | Rat | curcumin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Curcumin analog results in increased expression of GCLM mRNA more ... | CTD | PMID:17198877 more ... |
Gclm | Rat | curcumin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of GCLM mRNA] and NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of GCLM mRNA] | CTD | PMID:23954767 |
Gclm | Rat | curcumin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Curcumin results in increased expression of GCLM mRNA | CTD | PMID:17535857 more ... |
Gclm | Rat | curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of GCLM mRNA and Curcumin results in increased expression of GCLM protein | CTD | PMID:17602960 and PMID:18332871 |
Gclm | Rat | cycloheximide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]] more ... | CTD | PMID:19328227 |
Gclm | Rat | cyclosporin A | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GCLM mRNA | CTD | PMID:20106945 more ... |
Gclm | Rat | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of GCLM mRNA | CTD | PMID:11589784 and PMID:25596134 |
Gclm | Rat | D-glucose | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | D-glucose | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | DDT | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | DDT results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | deguelin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | deguelin results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | delta-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | CTD | PMID:22389237 |
Gclm | Rat | demethoxycurcumin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | demethoxycurcumin results in increased expression of GCLM mRNA | CTD | PMID:17535857 |
Gclm | Rat | demethoxycurcumin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | demethoxycurcumin results in increased expression of GCLM mRNA and demethoxycurcumin results in increased expression of GCLM protein | CTD | PMID:19188863 and PMID:23386263 |
Gclm | Rat | deoxycholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA more ... | CTD | PMID:17724089 and PMID:33819548 |
Gclm | Rat | deoxynivalenol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | deoxynivalenol results in increased expression of GCLM mRNA | CTD | PMID:34400200 |
Gclm | Rat | dexamethasone | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of GCLM mRNA | CTD | PMID:33412187 |
Gclm | Rat | dextran sulfate | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLM mRNA | CTD | PMID:29950665 |
Gclm | Rat | dextromethorphan | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | PRKCD protein affects the reaction [Dextromethorphan affects the expression of GCLM mRNA] more ... | CTD | PMID:34740715 |
Gclm | Rat | dextromethorphan | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Dextromethorphan affects the expression of GCLM mRNA | CTD | PMID:34740715 |
Gclm | Rat | diallyl disulfide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | diallyl disulfide promotes the reaction [lipopolysaccharide more ... | CTD | PMID:34896185 |
Gclm | Rat | diallyl disulfide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | diallyl disulfide results in increased expression of GCLM mRNA | CTD | PMID:34887701 |
Gclm | Rat | diallyl disulfide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | diallyl disulfide results in increased expression of GCLM mRNA | CTD | PMID:34896185 |
Gclm | Rat | diallyl trisulfide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | diallyl trisulfide results in increased expression of GCLM mRNA | CTD | PMID:34887701 |
Gclm | Rat | Diallyltetrasulfane | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | diallyl tetrasulfide results in increased expression of GCLM mRNA | CTD | PMID:34887701 |
Gclm | Rat | diarsenic trioxide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GCLM mRNA | CTD | PMID:15725085 more ... |
Gclm | Rat | diarsenic trioxide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of GCLM protein | CTD | PMID:25341331 |
Gclm | Rat | diarsenic trioxide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLM mRNA more ... | CTD | PMID:19350554 more ... |
Gclm | Rat | diazinon | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Diazinon results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | Dibutyl phosphate | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of GCLM mRNA | CTD | PMID:37042841 |
Gclm | Rat | dibutyl phthalate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of GCLM mRNA | CTD | PMID:21266533 |
Gclm | Rat | dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of GCLM mRNA | CTD | PMID:18636392 |
Gclm | Rat | diclofenac | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | Diclofenac affects the expression of GCLM mRNA | CTD | PMID:24752500 |
Gclm | Rat | diethyl malate | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] | CTD | PMID:24814887 |
Gclm | Rat | diethyl malate | affects expression | ISO | Gclm (Mus musculus) | 6480464 | diethyl malate affects the expression of GCLM mRNA | CTD | PMID:24814887 |
Gclm | Rat | diethyl maleate | increases expression | EXP | | 6480464 | diethyl maleate results in increased expression of GCLM mRNA and diethyl maleate results in increased expression of GCLM protein | CTD | PMID:10978506 more ... |
Gclm | Rat | diethyl maleate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of GCLM mRNA | CTD | PMID:33545341 and PMID:34480604 |
Gclm | Rat | diethyl maleate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | diethyl maleate results in increased expression of GCLM mRNA | CTD | PMID:25270620 |
Gclm | Rat | dihydrogen | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Hydrogen inhibits the reaction [Chlorpyrifos results in decreased expression of GCLM mRNA] | CTD | PMID:32955216 |
Gclm | Rat | dimethyl fumarate | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLM mRNA] | CTD | PMID:27277809 |
Gclm | Rat | dimethyl fumarate | increases expression | EXP | | 6480464 | Dimethyl Fumarate results in increased expression of GCLM protein | CTD | PMID:27277809 |
Gclm | Rat | dimethyl fumarate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Dimethyl Fumarate results in increased expression of GCLM mRNA | CTD | PMID:27277809 |
Gclm | Rat | dimethylarsinic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GCLM protein | CTD | PMID:33434570 |
Gclm | Rat | dinoseb | increases expression | ISO | Gclm (Mus musculus) | 6480464 | dinoseb results in increased expression of GCLM mRNA | CTD | PMID:30547568 |
Gclm | Rat | dioxygen | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GCLM mRNA | CTD | PMID:25596134 more ... |
Gclm | Rat | dioxygen | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of GCLM mRNA | CTD | PMID:29966676 |
Gclm | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Antimony Potassium Tartrate results in increased expression of GCLM mRNA | CTD | PMID:28713220 |
Gclm | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA | CTD | PMID:32076005 |
Gclm | Rat | diprotium | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Hydrogen inhibits the reaction [Chlorpyrifos results in decreased expression of GCLM mRNA] | CTD | PMID:32955216 |
Gclm | Rat | diquat | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Diquat results in increased expression of GCLM mRNA and Diquat results in increased expression of GCLM protein | CTD | PMID:21172416 and PMID:38128689 |
Gclm | Rat | diquat | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Diquat results in increased expression of GCLM mRNA | CTD | PMID:16962985 and PMID:20826540 |
Gclm | Rat | disulfiram | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Disulfiram results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | dodecan-1-ol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Dodecanol analog results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | domoic acid | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | [GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to 2 more ... | CTD | PMID:19200344 and PMID:23315585 |
Gclm | Rat | domoic acid | affects response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM affects the susceptibility to domoic acid | CTD | PMID:17804861 |
Gclm | Rat | domoic acid | increases expression | ISO | Gclm (Mus musculus) | 6480464 | domoic acid results in increased expression of GCLM mRNA and domoic acid results in increased expression of GCLM protein | CTD | PMID:23315585 |
Gclm | Rat | dopamine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [GCLM gene mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine | CTD | PMID:23704229 |
Gclm | Rat | dorsomorphin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLM mRNA | CTD | PMID:31697998 |
Gclm | Rat | dorsomorphin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Gclm | Rat | doxorubicin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] promotes the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] | CTD | PMID:10900222 |
Gclm | Rat | doxorubicin | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of GCLM mRNA | CTD | PMID:37499777 |
Gclm | Rat | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of GCLM mRNA | CTD | PMID:30588110 and PMID:37499777 |
Gclm | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | celastrol inhibits the reaction [Doxorubicin results in decreased expression of GCLM mRNA] more ... | CTD | PMID:30588110 and PMID:37499777 |
Gclm | Rat | doxorubicin | increases metabolic processing | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form results in increased metabolism of Doxorubicin | CTD | PMID:25446851 |
Gclm | Rat | doxorubicin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [GCLM gene mutant form results in increased metabolism of Doxorubicin] which results in increased abundance of adriamycinol more ... | CTD | PMID:25446851 more ... |
Gclm | Rat | doxorubicin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Doxorubicin results in increased expression of GCLM protein | CTD | PMID:26822305 |
Gclm | Rat | elesclomol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [elesclomol results in increased expression of GCLM mRNA] | CTD | PMID:18723479 |
Gclm | Rat | elesclomol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | elesclomol results in increased expression of GCLM mRNA | CTD | PMID:18723479 |
Gclm | Rat | emodin | increases expression | EXP | | 6480464 | Emodin results in increased expression of GCLM mRNA | CTD | PMID:34971761 |
Gclm | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of GCLM mRNA | CTD | PMID:29391264 |
Gclm | Rat | entinostat | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | entinostat | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | entinostat results in increased expression of GCLM mRNA | CTD | PMID:26272509 |
Gclm | Rat | enzyme inhibitor | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GCLM protein | CTD | PMID:23301498 |
Gclm | Rat | epichlorohydrin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Epichlorohydrin results in increased expression of GCLM mRNA | CTD | PMID:24211530 |
Gclm | Rat | Epomediol | multiple interactions | EXP | | 6480464 | [Ethinyl Estradiol co-treated with epomediol] results in increased activity of GCLM protein | CTD | PMID:12071332 |
Gclm | Rat | erastin | increases expression | EXP | | 6480464 | erastin results in increased expression of GCLM protein | CTD | PMID:32937103 |
Gclm | Rat | erastin | multiple interactions | EXP | | 6480464 | NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLM protein] | CTD | PMID:32937103 |
Gclm | Rat | erdosteine | increases expression | ISO | Gclm (Mus musculus) | 6480464 | erdosteine results in increased expression of GCLM protein | CTD | PMID:26193055 |
Gclm | Rat | etacrynic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Ethacrynic Acid | CTD | PMID:10900222 |
Gclm | Rat | ethanol | affects splicing | ISO | Gclm (Mus musculus) | 6480464 | Ethanol affects the splicing of GCLM mRNA | CTD | PMID:30319688 |
Gclm | Rat | ethionamide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA] | CTD | PMID:26708503 |
Gclm | Rat | ethylene glycol dimethacrylate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | ethylene dimethacrylate results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | etomoxir | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [etomoxir co-treated with osteum] results in increased expression of GCLM mRNA | CTD | PMID:38631510 |
Gclm | Rat | etoposide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] and [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Etoposide | CTD | PMID:10900222 |
Gclm | Rat | eugenol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Eugenol results in increased expression of GCLM mRNA | CTD | PMID:20566472 more ... |
Gclm | Rat | fenofibrate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Fenofibrate results in increased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | fenpyroximate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | fenpyroximate results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | fluprostenol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | AL 8810 inhibits the reaction [fluprostenol promotes the reaction [Oxidopamine results in increased expression of GCLM mRNA]] more ... | CTD | PMID:33486071 |
Gclm | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of GCLM mRNA | CTD | PMID:24136188 |
Gclm | Rat | folic acid | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GCLM mRNA | CTD | PMID:20938992 |
Gclm | Rat | folpet | increases expression | ISO | Gclm (Mus musculus) | 6480464 | folpet results in increased expression of GCLM mRNA | CTD | PMID:31558096 |
Gclm | Rat | formaldehyde | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of GCLM mRNA | CTD | PMID:23649840 |
Gclm | Rat | formononetin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [formononetin co-treated with Hydrogen Peroxide] results in increased expression of GCLM protein more ... | CTD | PMID:34077701 |
Gclm | Rat | fumonisin B1 | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | fumonisin B1 results in decreased expression of GCLM mRNA | CTD | PMID:35697133 |
Gclm | Rat | furosemide | multiple interactions | EXP | | 6480464 | [Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in decreased expression of GCLM mRNA and [Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in decreased expression of GCLM mRNA | CTD | PMID:29860548 |
Gclm | Rat | gamma-hexachlorocyclohexane | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | gamma-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] | CTD | PMID:22389237 |
Gclm | Rat | Gastrodin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | Gastrodin | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | gedunin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | gedunin results in increased expression of GCLM mRNA | CTD | PMID:17010675 |
Gclm | Rat | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of GCLM mRNA | CTD | PMID:12075121 |
Gclm | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GCLM mRNA | CTD | PMID:33387578 |
Gclm | Rat | geranial | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | citral results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | Ginkgolide C | multiple interactions | EXP | | 6480464 | ginkgolide C inhibits the reaction [Paraquat results in decreased expression of GCLM protein] | CTD | PMID:35707280 |
Gclm | Rat | ginsenoside Rg1 | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | ginsenoside Rg1 inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein] | CTD | PMID:29964319 |
Gclm | Rat | ginsenoside Rg1 | increases expression | ISO | Gclm (Mus musculus) | 6480464 | ginsenoside Rg1 results in increased expression of GCLM protein | CTD | PMID:29964319 |
Gclm | Rat | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of GCLM mRNA | CTD | PMID:24136188 |
Gclm | Rat | glucose | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | glucose | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA | CTD | PMID:33764184 |
Gclm | Rat | glutathione | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Chenodeoxycholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione more ... | CTD | PMID:12975258 and PMID:17724089 |
Gclm | Rat | glutathione | increases abundance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene SNP results in increased abundance of Glutathione | CTD | PMID:32715377 |
Gclm | Rat | glutathione | increases chemical synthesis | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein results in increased chemical synthesis of Glutathione | CTD | PMID:22253057 and PMID:23135907 |
Gclm | Rat | glutathione | affects response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein affects the susceptibility to Glutathione | CTD | PMID:17584759 |
Gclm | Rat | glutathione | decreases abundance | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form results in decreased abundance of Glutathione and GCLM protein mutant form results in decreased abundance of Glutathione | CTD | PMID:20417186 more ... |
Gclm | Rat | glutathione | increases expression | EXP | | 6480464 | Glutathione deficiency results in increased expression of GCLM mRNA | CTD | PMID:15345336 and PMID:20621112 |
Gclm | Rat | glutathione | affects metabolic processing | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein affects the metabolism of Glutathione | CTD | PMID:22253057 |
Gclm | Rat | glutathione | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [GCLM gene mutant form results in decreased abundance of Glutathione] which results in decreased susceptibility to Benzo(a)pyrene more ... | CTD | PMID:20159942 more ... |
Gclm | Rat | Glutathione ethyl ester | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] | CTD | PMID:24814887 |
Gclm | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GCLM mRNA more ... | CTD | PMID:33819548 |
Gclm | Rat | glycocholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GCLM mRNA more ... | CTD | PMID:33819548 |
Gclm | Rat | glycodeoxycholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GCLM mRNA more ... | CTD | PMID:33819548 |
Gclm | Rat | glyoxal | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Glyoxal results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | glyphosate | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Glyphosate results in decreased expression of GCLM protein | CTD | PMID:37208198 |
Gclm | Rat | guggulsterone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | pregna-4 more ... | CTD | PMID:22851183 |
Gclm | Rat | guggulsterone | increases expression | ISO | Gclm (Mus musculus) | 6480464 | pregna-4 more ... | CTD | PMID:22851183 |
Gclm | Rat | GW 4064 | increases expression | ISO | Gclm (Mus musculus) | 6480464 | GW 4064 results in increased expression of GCLM mRNA | CTD | PMID:26655953 |
Gclm | Rat | hemin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Hemin results in increased expression of GCLM mRNA and Hemin results in increased expression of GCLM protein | CTD | PMID:33434570 |
Gclm | Rat | hemin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLM mRNA and [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLM protein | CTD | PMID:33434570 |
Gclm | Rat | hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of GCLM mRNA | CTD | PMID:15159207 |
Gclm | Rat | hexadecanoic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein and Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein] | CTD | PMID:36905866 |
Gclm | Rat | hexamethylene diisocyanate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 1 and 6-hexamethylene diisocyanate results in increased expression of GCLM mRNA | CTD | PMID:24211530 |
Gclm | Rat | hexane | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | n-hexane results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | homoeriodictyol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | homoeriodictyol results in increased expression of GCLM mRNA | CTD | PMID:29902531 |
Gclm | Rat | hydrogen chloride | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Hydrochloric Acid results in increased expression of GCLM mRNA] | CTD | PMID:29618784 |
Gclm | Rat | hydrogen chloride | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Hydrochloric Acid results in increased expression of GCLM mRNA | CTD | PMID:29618784 |
Gclm | Rat | hydrogen peroxide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of GCLM mRNA | CTD | PMID:18951874 and PMID:29274434 |
Gclm | Rat | hydrogen peroxide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [formononetin co-treated with Hydrogen Peroxide] results in increased expression of GCLM protein more ... | CTD | PMID:29274434 more ... |
Gclm | Rat | hydrogen peroxide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of GCLM mRNA and Hydrogen Peroxide results in increased expression of GCLM protein | CTD | PMID:12414654 more ... |
Gclm | Rat | hydrogen peroxide | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | [GCLM protein results in decreased susceptibility to domoic acid] which results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:23315585 |
Gclm | Rat | hydroquinone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | hydroquinone results in increased expression of GCLM mRNA and hydroquinone results in increased expression of GCLM protein | CTD | PMID:21059386 and PMID:31256213 |
Gclm | Rat | hydroquinone | increases expression | ISO | Gclm (Mus musculus) | 6480464 | hydroquinone results in increased expression of GCLM mRNA and hydroquinone results in increased expression of GCLM protein | CTD | PMID:30547568 |
Gclm | Rat | hypochlorous acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Hypochlorous Acid results in increased expression of GCLM mRNA | CTD | PMID:18156441 |
Gclm | Rat | hypochlorous acid | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of GCLM mRNA | CTD | PMID:19376150 |
Gclm | Rat | ibuprofen | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ibuprofen results in increased expression of GCLM mRNA | CTD | PMID:11909699 and PMID:25596134 |
Gclm | Rat | ifosfamide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ifosfamide results in increased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | indometacin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Indomethacin results in increased expression of GCLM mRNA | CTD | PMID:11909699 |
Gclm | Rat | indometacin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of GCLM mRNA | CTD | PMID:33412187 |
Gclm | Rat | iodixanol | multiple interactions | EXP | | 6480464 | [Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in decreased expression of GCLM mRNA | CTD | PMID:29860548 |
Gclm | Rat | iohexol | multiple interactions | EXP | | 6480464 | [Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in decreased expression of GCLM mRNA | CTD | PMID:29860548 |
Gclm | Rat | iron atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLM mRNA] | CTD | PMID:19073151 |
Gclm | Rat | iron atom | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Iron results in decreased expression of GCLM mRNA | CTD | PMID:19073151 |
Gclm | Rat | iron(0) | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLM mRNA] | CTD | PMID:19073151 |
Gclm | Rat | iron(0) | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Iron results in decreased expression of GCLM mRNA | CTD | PMID:19073151 |
Gclm | Rat | iron(III) citrate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | ferric citrate results in increased expression of GCLM mRNA | CTD | PMID:29959986 |
Gclm | Rat | isoeugenol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | isoeugenol results in increased expression of GCLM mRNA | CTD | PMID:20566472 more ... |
Gclm | Rat | isoflavones | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Isoflavones results in increased expression of GCLM mRNA | CTD | PMID:17374662 |
Gclm | Rat | isoniazide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Isoniazid results in increased expression of GCLM mRNA | CTD | PMID:33771660 |
Gclm | Rat | isoniazide | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [Isoniazid results in increased expression of GCLM mRNA] | CTD | PMID:33121995 |
Gclm | Rat | isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of GCLM mRNA | CTD | PMID:33121995 |
Gclm | Rat | isoniazide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Isoniazid results in decreased expression of GCLM mRNA | CTD | PMID:30008028 |
Gclm | Rat | isoprenaline | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Isoproterenol results in increased expression of GCLM mRNA | CTD | PMID:20003209 |
Gclm | Rat | isoprenaline | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with POSTN protein] results in decreased expression of GCLM mRNA | CTD | PMID:30303030 |
Gclm | Rat | isoprenaline | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of GCLM mRNA | CTD | PMID:21335049 |
Gclm | Rat | isotretinoin | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of GCLM mRNA | CTD | PMID:20436886 |
Gclm | Rat | ivermectin | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of GCLM protein | CTD | PMID:32959892 |
Gclm | Rat | ketoprofen | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ketoprofen results in increased expression of GCLM mRNA | CTD | PMID:11909699 |
Gclm | Rat | L-ascorbic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mRNA | CTD | PMID:34480604 |
Gclm | Rat | L-ascorbic acid 2-phosphate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mRNA | CTD | PMID:34480604 |
Gclm | Rat | L-methionine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GCLM mRNA | CTD | PMID:20938992 |
Gclm | Rat | lead diacetate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | lead acetate results in increased expression of GCLM mRNA | CTD | PMID:25270620 |
Gclm | Rat | lead diacetate | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of GCLM mRNA | CTD | PMID:39276841 |
Gclm | Rat | lead diacetate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLM mRNA] | CTD | PMID:26498409 |
Gclm | Rat | lead diacetate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | lead acetate results in increased expression of GCLM mRNA | CTD | PMID:26498409 and PMID:38568856 |
Gclm | Rat | lead(0) | affects abundance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene polymorphism affects the abundance of Lead | CTD | PMID:25728017 |
Gclm | Rat | lead(0) | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Lead results in increased expression of GCLM mRNA | CTD | PMID:37386098 |
Gclm | Rat | lead(0) | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of GCLM mRNA | CTD | PMID:39276841 |
Gclm | Rat | lead(II) chloride | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | lead chloride results in increased expression of GCLM mRNA | CTD | PMID:38447685 |
Gclm | Rat | limonene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | limonene results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | linoleic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Linoleic Acid metabolite results in increased expression of GCLM mRNA | CTD | PMID:26879219 |
Gclm | Rat | lipoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Thioctic Acid results in increased expression of GCLM mRNA and Thioctic Acid results in increased expression of GCLM protein | CTD | PMID:16249512 and PMID:26365678 |
Gclm | Rat | lipoic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Thioctic Acid promotes the reaction [Cadmium Chloride results in increased expression of GCLM mRNA] and Thioctic Acid promotes the reaction [Cadmium Chloride results in increased expression of GCLM protein] | CTD | PMID:26365678 |
Gclm | Rat | lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of GCLM mRNA] and Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of GCLM protein] | CTD | PMID:32061141 |
Gclm | Rat | lipopolysaccharide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of GCLM mRNA | CTD | PMID:19339665 |
Gclm | Rat | lipopolysaccharide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 |
Gclm | Rat | lipopolysaccharide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 8-oxoberberine promotes the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of GCLM mRNA] more ... | CTD | PMID:19339665 more ... |
Gclm | Rat | lipopolysaccharide | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Lipopolysaccharides affects the expression of GCLM mRNA | CTD | PMID:22169119 |
Gclm | Rat | liquiritigenin | increases expression | EXP | | 6480464 | liquiritigenin results in increased expression of GCLM protein | CTD | PMID:29908794 |
Gclm | Rat | liquiritigenin | multiple interactions | EXP | | 6480464 | liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GCLM mRNA] | CTD | PMID:29908794 |
Gclm | Rat | liquiritin | multiple interactions | EXP | | 6480464 | liquiritin inhibits the reaction [Monocrotaline results in decreased expression of GCLM mRNA] | CTD | PMID:29908794 |
Gclm | Rat | liquiritin | increases expression | EXP | | 6480464 | liquiritin results in increased expression of GCLM protein | CTD | PMID:29908794 |
Gclm | Rat | lithocholic acid | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | Lithocholic Acid affects the expression of GCLM mRNA and Lithocholic Acid affects the expression of GCLM protein | CTD | PMID:20146260 |
Gclm | Rat | lithocholic acid | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Lithocholic Acid results in decreased expression of GCLM mRNA | CTD | PMID:29794447 |
Gclm | Rat | lithocholic acid | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA and Vardenafil Dihydrochloride inhibits the reaction [Lithocholic Acid results in decreased expression of GCLM mRNA] | CTD | PMID:17724089 and PMID:29794447 |
Gclm | Rat | lithocholic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Lithocholic Acid results in increased expression of GCLM protein | CTD | PMID:17724089 |
Gclm | Rat | lithocholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA more ... | CTD | PMID:17724089 |
Gclm | Rat | luteolin | increases expression | EXP | | 6480464 | Luteolin results in increased expression of GCLM mRNA and Luteolin results in increased expression of GCLM protein | CTD | PMID:22864849 |
Gclm | Rat | Luteolin 7-methyl ether | increases expression | EXP | | 6480464 | hydroxygenkwanin results in increased expression of GCLM mRNA | CTD | PMID:38942164 |
Gclm | Rat | LY294002 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GCLM protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLM mRNA] | CTD | PMID:19073151 more ... |
Gclm | Rat | LY294002 | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]] | CTD | PMID:25895139 |
Gclm | Rat | LY294002 | decreases activity | ISO | GCLM (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of GCLM protein | CTD | PMID:16972261 |
Gclm | Rat | LY294002 | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GCLM mRNA | CTD | PMID:19073151 |
Gclm | Rat | lycopene | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Lycopene results in increased expression of GCLM protein | CTD | PMID:36216167 |
Gclm | Rat | lycopene | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of GCLM mRNA] and Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GCLM mRNA] | CTD | PMID:35917956 and PMID:36216167 |
Gclm | Rat | malonaldehyde | affects abundance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene polymorphism affects the abundance of Malondialdehyde | CTD | PMID:25728017 |
Gclm | Rat | manganese atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCLM mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GCLM mRNA | CTD | PMID:38503349 and PMID:39836092 |
Gclm | Rat | manganese(0) | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCLM mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GCLM mRNA | CTD | PMID:38503349 and PMID:39836092 |
Gclm | Rat | manganese(II) chloride | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCLM mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GCLM mRNA | CTD | PMID:38503349 and PMID:39836092 |
Gclm | Rat | melatonin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA]] more ... | CTD | PMID:25550330 |
Gclm | Rat | menadione | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Vitamin K 3 results in increased expression of GCLM mRNA | CTD | PMID:25270620 |
Gclm | Rat | menadione | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of GCLM mRNA | CTD | PMID:12414654 and PMID:23410634 |
Gclm | Rat | mercaptopurine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Mercaptopurine results in increased expression of GCLM mRNA | CTD | PMID:18222062 |
Gclm | Rat | mercury atom | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Mercury results in decreased expression of GCLM mRNA | CTD | PMID:19937285 |
Gclm | Rat | mercury atom | affects metabolic processing | ISO | GCLM (Homo sapiens) | 6480464 | GCLM polymorphism affects the metabolism of Mercury | CTD | PMID:16961004 |
Gclm | Rat | mercury atom | affects abundance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene polymorphism affects the abundance of Mercury and GCLM protein affects the abundance of Mercury | CTD | PMID:18560528 and PMID:21925580 |
Gclm | Rat | mercury dibromide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of GCLM mRNA | CTD | PMID:26272509 |
Gclm | Rat | mercury dibromide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | mercury dichloride | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Mercuric Chloride results in increased expression of GCLM mRNA | CTD | PMID:24039982 |
Gclm | Rat | mercury dichloride | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | mercury dichloride | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | ABCC2 gene mutant form promotes the reaction [Mercuric Chloride results in increased expression of GCLM mRNA] | CTD | PMID:24039982 |
Gclm | Rat | mercury(0) | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Mercury results in decreased expression of GCLM mRNA | CTD | PMID:19937285 |
Gclm | Rat | mercury(0) | affects metabolic processing | ISO | GCLM (Homo sapiens) | 6480464 | GCLM polymorphism affects the metabolism of Mercury | CTD | PMID:16961004 |
Gclm | Rat | mercury(0) | affects abundance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene polymorphism affects the abundance of Mercury and GCLM protein affects the abundance of Mercury | CTD | PMID:18560528 and PMID:21925580 |
Gclm | Rat | mesalamine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Mesalamine promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA] | CTD | PMID:27818126 |
Gclm | Rat | metam | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of GCLM mRNA] | CTD | PMID:19339665 |
Gclm | Rat | metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | metformin | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Metformin results in decreased expression of GCLM mRNA | CTD | PMID:33838154 |
Gclm | Rat | metformin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Metformin results in increased expression of GCLM mRNA | CTD | PMID:25596134 |
Gclm | Rat | methidathion | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | methidathion results in decreased expression of GCLM mRNA | CTD | PMID:34813904 |
Gclm | Rat | methyl methacrylate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Methylmethacrylate results in increased expression of GCLM mRNA | CTD | PMID:16916219 |
Gclm | Rat | methyl methanesulfonate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GCLM mRNA | CTD | PMID:23649840 |
Gclm | Rat | methyl salicylate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | methyl salicylate results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | methylene blue | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of GCLM mRNA | CTD | PMID:24556215 |
Gclm | Rat | methylisothiazolinone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of GCLM mRNA | CTD | PMID:30806763 |
Gclm | Rat | methylmercury chloride | increases expression | ISO | Gclm (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of GCLM mRNA | CTD | PMID:20061341 |
Gclm | Rat | methylmercury chloride | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of GCLM mRNA] and Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of GCLM protein] | CTD | PMID:32061141 |
Gclm | Rat | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of GCLM mRNA and methylmercuric chloride results in increased expression of GCLM protein | CTD | PMID:32061141 |
Gclm | Rat | methylmercury chloride | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | methylmercury chloride | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GCLM mRNA | CTD | PMID:23179753 more ... |
Gclm | Rat | metronidazole | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein] | CTD | PMID:36535435 |
Gclm | Rat | mifepristone | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Mifepristone results in increased expression of GCLM protein | CTD | PMID:16840778 |
Gclm | Rat | mifepristone | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]] and Mifepristone results in increased activity of [GCLC protein binds to GCLM protein] | CTD | PMID:16840778 |
Gclm | Rat | monascin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | monascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA] and NFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]] | CTD | PMID:23331247 |
Gclm | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of GCLM mRNA | CTD | PMID:34863575 |
Gclm | Rat | monocrotaline | multiple interactions | EXP | | 6480464 | liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GCLM mRNA] and liquiritin inhibits the reaction [Monocrotaline results in decreased expression of GCLM mRNA] | CTD | PMID:29908794 |
Gclm | Rat | monocrotaline | decreases expression | EXP | | 6480464 | Monocrotaline results in decreased expression of GCLM mRNA | CTD | PMID:29908794 |
Gclm | Rat | motexafin gadolinium | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GCLM mRNA | CTD | PMID:16357179 |
Gclm | Rat | motexafin gadolinium | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | motexafin gadolinium results in increased expression of GCLM mRNA | CTD | PMID:16357179 |
Gclm | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of GCLM mRNA] and Acetylcysteine inhibits the reaction [elesclomol results in increased expression of GCLM mRNA] | CTD | PMID:18723479 and PMID:19350554 |
Gclm | Rat | N-acetyl-L-cysteine | affects response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein affects the susceptibility to Acetylcysteine | CTD | PMID:17584759 |
Gclm | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Acetylcysteine co-treated with Acetaminophen] results in decreased expression of GCLM mRNA and Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLM mRNA] | CTD | PMID:19328227 and PMID:37598316 |
Gclm | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Gclm (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GCLM mRNA | CTD | PMID:20061341 |
Gclm | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLM mRNA and [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLM protein | CTD | PMID:33434570 |
Gclm | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GCLM mRNA and benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GCLM protein | CTD | PMID:33434570 |
Gclm | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of GCLM protein | CTD | PMID:26558463 |
Gclm | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLM mRNA | CTD | PMID:16158176 |
Gclm | Rat | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of GCLM protein | CTD | PMID:19716841 |
Gclm | Rat | N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLM mRNA | CTD | PMID:22851183 |
Gclm | Rat | N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLM mRNA | CTD | PMID:22851183 |
Gclm | Rat | naphthalene | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | naphthalene results in decreased expression of GCLM mRNA | CTD | PMID:31020322 |
Gclm | Rat | naproxen | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Naproxen results in increased expression of GCLM mRNA | CTD | PMID:11909699 |
Gclm | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of GCLM mRNA | CTD | PMID:24136188 |
Gclm | Rat | neoastilbin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | astilbin promotes the reaction [Cisplatin results in increased expression of GCLM mRNA] | CTD | PMID:29471006 |
Gclm | Rat | neomycin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein] | CTD | PMID:36535435 |
Gclm | Rat | nickel atom | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Nickel results in increased expression of GCLM mRNA | CTD | PMID:25583101 |
Gclm | Rat | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of GCLM mRNA | CTD | PMID:22110744 |
Gclm | Rat | nickel sulfate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of GCLM mRNA | CTD | PMID:16314067 and PMID:20566472 |
Gclm | Rat | niclosamide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of GCLM mRNA | CTD | PMID:36318118 |
Gclm | Rat | nilotinib | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of GCLM mRNA] | CTD | PMID:23883479 |
Gclm | Rat | nilotinib | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | nilotinib results in increased expression of GCLM mRNA | CTD | PMID:23883479 |
Gclm | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of GCLM mRNA | CTD | PMID:24136188 |
Gclm | Rat | nitisinone | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [nitisinone results in decreased activity of HPD protein] which results in decreased expression of GCLM mRNA | CTD | PMID:12899938 |
Gclm | Rat | nitric oxide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene SNP affects the abundance of and affects the activity of and affects the susceptibility to Nitric Oxide | CTD | PMID:12975258 |
Gclm | Rat | nitrogen dioxide | decreases expression | EXP | | 6480464 | Nitrogen Dioxide results in decreased expression of GCLM mRNA | CTD | PMID:16049373 |
Gclm | Rat | Nonidet P-40 | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Nonidet P-40 results in increased expression of GCLM mRNA | CTD | PMID:26552463 |
Gclm | Rat | Nutlin-3 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of GCLM protein | CTD | PMID:38460933 |
Gclm | Rat | obeticholic acid | increases expression | ISO | Gclm (Mus musculus) | 6480464 | obeticholic acid results in increased expression of GCLM mRNA | CTD | PMID:26655953 |
Gclm | Rat | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of GCLM mRNA | CTD | PMID:16251485 and PMID:18417182 |
Gclm | Rat | ochratoxin A | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of GCLM mRNA | CTD | PMID:30559759 |
Gclm | Rat | ochratoxin A | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | ochratoxin A affects the expression of GCLM mRNA | CTD | PMID:30008028 |
Gclm | Rat | oleanolic acid | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Oleanolic Acid results in increased expression of GCLM mRNA | CTD | PMID:18706400 |
Gclm | Rat | oleic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein and Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLM protein] | CTD | PMID:36905866 |
Gclm | Rat | organoselenium compound | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Organoselenium Compounds binds to Copper] which results in increased expression of GCLM mRNA | CTD | PMID:25167922 |
Gclm | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of GCLM mRNA | CTD | PMID:25729387 |
Gclm | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCLM mRNA | CTD | PMID:25729387 |
Gclm | Rat | oxidopamine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Oxidopamine results in increased expression of GCLM mRNA | CTD | PMID:33486071 |
Gclm | Rat | oxidopamine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | AL 8810 inhibits the reaction [fluprostenol promotes the reaction [Oxidopamine results in increased expression of GCLM mRNA]] more ... | CTD | PMID:25446857 and PMID:33486071 |
Gclm | Rat | oxidopamine | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Oxidopamine results in decreased expression of GCLM protein | CTD | PMID:25446857 |
Gclm | Rat | oxidopamine | multiple interactions | EXP | | 6480464 | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLM protein] | CTD | PMID:25446857 |
Gclm | Rat | oxidopamine | decreases expression | EXP | | 6480464 | Oxidopamine results in decreased expression of GCLM protein | CTD | PMID:25446857 |
Gclm | Rat | ozone | affects response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form affects the susceptibility to Ozone | CTD | PMID:20417186 |
Gclm | Rat | ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of GCLM mRNA | CTD | PMID:18636392 |
Gclm | Rat | ozone | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of MT1 mRNA] more ... | CTD | PMID:20417186 |
Gclm | Rat | p-chloromercuribenzoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of GCLM mRNA | CTD | PMID:26272509 |
Gclm | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | p-toluidine | increases expression | EXP | | 6480464 | 4-toluidine results in increased expression of GCLM mRNA | CTD | PMID:27638505 |
Gclm | Rat | para-Cresidine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | cresidine results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | paracetamol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA more ... | CTD | PMID:25881548 more ... |
Gclm | Rat | paracetamol | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of GCLM mRNA | CTD | PMID:25818464 more ... |
Gclm | Rat | paracetamol | affects response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein affects the susceptibility to Acetaminophen | CTD | PMID:17584759 |
Gclm | Rat | paracetamol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GCLM mRNA and Acetaminophen results in increased expression of GCLM protein | CTD | PMID:21420995 more ... |
Gclm | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GCLM mRNA | CTD | PMID:11245408 more ... |
Gclm | Rat | paracetamol | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein results in decreased susceptibility to Acetaminophen | CTD | PMID:18642143 |
Gclm | Rat | paracetamol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Acetaminophen results in increased expression of GCLM mRNA and Acetaminophen results in increased expression of GCLM protein | CTD | PMID:18468992 more ... |
Gclm | Rat | paracetamol | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLM mRNA more ... | CTD | PMID:16840778 more ... |
Gclm | Rat | paracetamol | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Acetaminophen affects the expression of GCLM mRNA | CTD | PMID:17562736 |
Gclm | Rat | paraoxon | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Paraoxon results in increased expression of GCLM mRNA | CTD | PMID:24413757 |
Gclm | Rat | paraquat | increases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form results in increased susceptibility to Paraquat | CTD | PMID:23704229 |
Gclm | Rat | paraquat | multiple interactions | EXP | | 6480464 | ginkgolide C inhibits the reaction [Paraquat results in decreased expression of GCLM protein] | CTD | PMID:35707280 |
Gclm | Rat | paraquat | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Paraquat results in increased expression of GCLM mRNA | CTD | PMID:34097952 and PMID:35182771 |
Gclm | Rat | paraquat | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Paraquat results in increased expression of GCLM mRNA | CTD | PMID:31216030 |
Gclm | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of GCLM protein | CTD | PMID:27993944 and PMID:35707280 |
Gclm | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of GCLM mRNA | CTD | PMID:28467894 |
Gclm | Rat | paraquat | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA | CTD | PMID:24530478 |
Gclm | Rat | paraquat | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [GCLM gene mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine more ... | CTD | PMID:23704229 and PMID:31216030 |
Gclm | Rat | PCB138 | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 |
Gclm | Rat | pentachlorophenol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of GCLM mRNA | CTD | PMID:23892564 |
Gclm | Rat | perfluorodecanoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | perfluorodecanoic acid results in increased expression of GCLM mRNA | CTD | PMID:23567314 |
Gclm | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Gclm (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of GCLM mRNA | CTD | PMID:37995155 |
Gclm | Rat | perfluorononanoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of GCLM mRNA | CTD | PMID:32588087 |
Gclm | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of GCLM mRNA | CTD | PMID:33772556 |
Gclm | Rat | perfluorooctanoic acid | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | perfluorooctanoic acid results in decreased expression of GCLM mRNA | CTD | PMID:30547568 |
Gclm | Rat | perfluorooctanoic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of GCLM mRNA | CTD | PMID:33772556 |
Gclm | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GCLM mRNA | CTD | PMID:19162173 |
Gclm | Rat | phenobarbital | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | Phenobarbital affects the expression of GCLM mRNA | CTD | PMID:19159669 |
Gclm | Rat | phenol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Phenol results in increased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | phenoxymethylpenicillin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Penicillin V results in increased expression of GCLM mRNA | CTD | PMID:22609641 |
Gclm | Rat | phenyl benzoate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | diphenylcarboxylate results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | phenylmercury acetate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of GCLM mRNA | CTD | PMID:26272509 |
Gclm | Rat | phenylmercury acetate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of GCLM mRNA | CTD | PMID:20345932 |
Gclm | Rat | phlorizin | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Phlorhizin results in decreased expression of GCLM mRNA | CTD | PMID:22538082 |
Gclm | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] and Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA] | CTD | PMID:24632381 |
Gclm | Rat | phorbol 13-acetate 12-myristate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of GCLM mRNA | CTD | PMID:24632381 |
Gclm | Rat | phorone | affects expression | EXP | | 6480464 | phorone affects the expression of GCLM mRNA | CTD | PMID:18198479 |
Gclm | Rat | phosgene | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Phosgene affects the expression of GCLM mRNA | CTD | PMID:16300373 |
Gclm | Rat | picoxystrobin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | plumbagin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | plumbagin results in increased expression of GCLM mRNA | CTD | PMID:20028456 |
Gclm | Rat | polymyxin B2 | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Polymyxin B results in increased expression of GCLM mRNA | CTD | PMID:37088170 |
Gclm | Rat | potassium bromate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | potassium bromate results in increased expression of GCLM mRNA | CTD | PMID:30008028 and PMID:30559759 |
Gclm | Rat | potassium bromate | increases methylation | ISO | GCLM (Homo sapiens) | 6480464 | potassium bromate results in increased methylation of GCLM promoter | CTD | PMID:30559759 |
Gclm | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of GCLM mRNA | CTD | PMID:19162173 |
Gclm | Rat | procyanidin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:39117098 |
Gclm | Rat | procyanidin B3 | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Eicosapentaenoic Acid co-treated with procyanidin B3 co-treated with Lipopolysaccharides] results in increased expression of GCLM mRNA | CTD | PMID:22169119 |
Gclm | Rat | propan-2-ol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 2-Propanol results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | prostaglandin J2 | increases expression | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLM mRNA and 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLM protein | CTD | PMID:18332871 |
Gclm | Rat | Prothionamide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Prothionamide co-treated with osteum] results in increased expression of GCLM mRNA | CTD | PMID:38631510 |
Gclm | Rat | purine-6-thiol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Mercaptopurine results in increased expression of GCLM mRNA | CTD | PMID:18222062 |
Gclm | Rat | pyrimidifen | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | quercetin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Quercetin results in increased expression of GCLM mRNA and Quercetin results in increased expression of GCLM protein | CTD | PMID:19183254 and PMID:27777014 |
Gclm | Rat | quercetin | increases activity | ISO | Gclm (Mus musculus) | 6480464 | Quercetin analog results in increased activity of GCLM protein | CTD | PMID:27777014 |
Gclm | Rat | quercetin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Quercetin results in increased expression of GCLM mRNA and Quercetin results in increased expression of GCLM protein | CTD | PMID:19576171 more ... |
Gclm | Rat | quercetin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Quercetin] results in increased expression of GCLM mRNA more ... | CTD | PMID:22197970 and PMID:25881548 |
Gclm | Rat | rac-lactic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | reactive oxygen species | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | CTD | PMID:22864849 |
Gclm | Rat | reactive oxygen species | decreases abundance | ISO | GCLM (Homo sapiens) | 6480464 | GCLM gene SNP results in decreased abundance of Reactive Oxygen Species | CTD | PMID:32715377 |
Gclm | Rat | reactive oxygen species | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Reactive Oxygen Species results in increased expression of GCLM mRNA | CTD | PMID:25800948 |
Gclm | Rat | resveratrol | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA and resveratrol promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mRNA] | CTD | PMID:19167446 and PMID:27818126 |
Gclm | Rat | resveratrol | increases expression | ISO | Gclm (Mus musculus) | 6480464 | resveratrol results in increased expression of GCLM mRNA | CTD | PMID:25808216 |
Gclm | Rat | rotenone | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Rotenone results in increased expression of GCLM mRNA | CTD | PMID:17657281 |
Gclm | Rat | rotenone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Rotenone results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | rotenone | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Rotenone affects the expression of GCLM mRNA | CTD | PMID:23186747 |
Gclm | Rat | rottlerin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]] more ... | CTD | PMID:25895139 more ... |
Gclm | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 |
Gclm | Rat | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of GCLM mRNA | CTD | PMID:35811015 and PMID:36576512 |
Gclm | Rat | S-(1,2-Dichlorovinyl)glutathione | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)glutathione results in increased expression of GCLM mRNA | CTD | PMID:36576512 |
Gclm | Rat | S-adenosyl-L-methioninate | decreases abundance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein mutant form results in decreased abundance of S-Adenosylmethionine | CTD | PMID:38830566 |
Gclm | Rat | S-adenosyl-L-methionine | decreases abundance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein mutant form results in decreased abundance of S-Adenosylmethionine | CTD | PMID:38830566 |
Gclm | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | EXP | | 6480464 | Buthionine Sulfoximine results in increased expression of GCLM mRNA | CTD | PMID:10978506 and PMID:19010381 |
Gclm | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Buthionine Sulfoximine inhibits the reaction [[Lithocholic Acid results in increased expression of GCLM protein] which results in increased abundance of Glutathione] | CTD | PMID:17724089 |
Gclm | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | CTD | PMID:22864849 |
Gclm | Rat | SB 203580 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [Quercetin results in increased expression of GCLM mRNA] | CTD | PMID:22197970 |
Gclm | Rat | SB 431542 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:34480604 |
Gclm | Rat | Securinine | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | securinine results in increased expression of GCLM mRNA | CTD | PMID:32662633 |
Gclm | Rat | sevoflurane | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Sevoflurane results in decreased expression of GCLM mRNA | CTD | PMID:35350913 |
Gclm | Rat | sevoflurane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of GCLM mRNA] | CTD | PMID:35350913 |
Gclm | Rat | silicon dioxide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Silicon Dioxide co-treated with Vitamin D] results in increased expression of GCLM mRNA | CTD | PMID:30698894 |
Gclm | Rat | silicon dioxide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of GCLM mRNA | CTD | PMID:30698894 |
Gclm | Rat | silver atom | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLM mRNA] | CTD | PMID:22546375 |
Gclm | Rat | silver atom | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Silver results in increased expression of GCLM mRNA | CTD | PMID:27131904 |
Gclm | Rat | silver atom | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Silver results in increased expression of GCLM mRNA | CTD | PMID:22036727 more ... |
Gclm | Rat | silver(0) | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLM mRNA] | CTD | PMID:22546375 |
Gclm | Rat | silver(0) | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Silver results in increased expression of GCLM mRNA | CTD | PMID:27131904 |
Gclm | Rat | silver(0) | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Silver results in increased expression of GCLM mRNA | CTD | PMID:22036727 more ... |
Gclm | Rat | SL-327 | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLM mRNA]] | CTD | PMID:25550330 |
Gclm | Rat | sodium arsenate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GCLM mRNA and [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GCLM protein | CTD | PMID:32525701 and PMID:33434570 |
Gclm | Rat | sodium arsenite | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCLM mRNA more ... | CTD | PMID:20805060 more ... |
Gclm | Rat | sodium arsenite | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of GCLM mRNA | CTD | PMID:35298964 and PMID:37956786 |
Gclm | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of GCLM mRNA and sodium arsenite results in increased expression of GCLM protein | CTD | PMID:21465251 |
Gclm | Rat | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of GCLM mRNA | CTD | PMID:25625412 |
Gclm | Rat | sodium arsenite | increases expression | ISO | Gclm (Mus musculus) | 6480464 | sodium arsenite results in increased expression of GCLM mRNA and sodium arsenite results in increased expression of GCLM protein | CTD | PMID:16014739 more ... |
Gclm | Rat | sodium arsenite | increases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM gene mutant form results in increased susceptibility to sodium arsenite | CTD | PMID:16014739 |
Gclm | Rat | sodium arsenite | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [GCLM co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of and results in increased cleavage of CASP3 protein] more ... | CTD | PMID:20006689 and PMID:34272803 |
Gclm | Rat | sodium arsenite | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GCLM mRNA and sodium arsenite results in increased expression of GCLM protein | CTD | PMID:12679051 more ... |
Gclm | Rat | sodium dichromate | increases expression | ISO | Gclm (Mus musculus) | 6480464 | sodium bichromate results in increased expression of GCLM mRNA | CTD | PMID:22155349 |
Gclm | Rat | sodium dichromate | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | sodium bichromate results in decreased expression of GCLM mRNA | CTD | PMID:22155349 |
Gclm | Rat | sodium dodecyl sulfate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of GCLM mRNA | CTD | PMID:20566472 |
Gclm | Rat | Sodium oleate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [etomoxir co-treated with osteum] results in increased expression of GCLM mRNA more ... | CTD | PMID:38631510 |
Gclm | Rat | spermidine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | pimagedine inhibits the reaction [Spermidine results in increased expression of GCLM mRNA] | CTD | PMID:12763045 |
Gclm | Rat | spermidine | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Spermidine results in increased expression of GCLM mRNA | CTD | PMID:12763045 |
Gclm | Rat | staurosporine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Staurosporine promotes the reaction [MYC protein binds to GCLM promoter] | CTD | PMID:17628013 |
Gclm | Rat | streptozocin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Dietary Fats co-treated with Streptozocin] results in decreased expression of GCLM mRNA | CTD | PMID:33359794 |
Gclm | Rat | succimer | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCLM mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLM mRNA | CTD | PMID:21641980 and PMID:26378955 |
Gclm | Rat | sulforaphane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GCLM mRNA] more ... | CTD | PMID:20932822 more ... |
Gclm | Rat | sulforaphane | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of GCLM mRNA | CTD | PMID:35724838 |
Gclm | Rat | sulforaphane | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [sulforaphane results in increased expression of GCLM protein] | CTD | PMID:35227738 |
Gclm | Rat | sulforaphane | increases expression | ISO | Gclm (Mus musculus) | 6480464 | sulforaphane results in increased expression of GCLM mRNA and sulforaphane results in increased expression of GCLM protein | CTD | PMID:19071154 more ... |
Gclm | Rat | sulforaphane | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | sulforaphane results in increased expression of GCLM more ... | CTD | PMID:20442190 more ... |
Gclm | Rat | sunitinib | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Sunitinib results in increased expression of GCLM mRNA | CTD | PMID:31533062 |
Gclm | Rat | Sunset Yellow FCF | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GCLM mRNA | CTD | PMID:33819548 |
Gclm | Rat | suprofen | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Suprofen results in increased expression of GCLM mRNA | CTD | PMID:11909699 |
Gclm | Rat | T-2 toxin | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | T-2 Toxin results in decreased expression of GCLM mRNA | CTD | PMID:20854872 |
Gclm | Rat | T-2 toxin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | T-2 Toxin results in increased expression of GCLM mRNA | CTD | PMID:33508416 |
Gclm | Rat | tartrazine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GCLM mRNA | CTD | PMID:33819548 |
Gclm | Rat | tebufenpyrad | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | tectorigenin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of GCLM protein and tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of GCLM mRNA] | CTD | PMID:37348807 |
Gclm | Rat | temozolomide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Temozolomide results in increased expression of GCLM mRNA | CTD | PMID:31758290 |
Gclm | Rat | tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide more ... | CTD | PMID:22864849 |
Gclm | Rat | tert-butyl hydroperoxide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | tert-Butylhydroperoxide results in increased expression of GCLM mRNA | CTD | PMID:30547568 |
Gclm | Rat | tert-butyl hydroperoxide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of GCLM mRNA | CTD | PMID:12414654 more ... |
Gclm | Rat | tetrachloromethane | affects expression | ISO | Gclm (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of GCLM mRNA | CTD | PMID:17484886 |
Gclm | Rat | tetrachloromethane | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of GCLM mRNA | CTD | PMID:32063085 |
Gclm | Rat | tetrachloromethane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | AK-1 compound promotes the reaction [Carbon Tetrachloride results in increased expression of GCLM mRNA] more ... | CTD | PMID:27477297 more ... |
Gclm | Rat | tetrachloromethane | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of GCLM mRNA and Carbon Tetrachloride results in decreased expression of GCLM protein | CTD | PMID:17484886 more ... |
Gclm | Rat | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of GCLM mRNA | CTD | PMID:15963342 |
Gclm | Rat | tetramethylpyrazine | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA]] more ... | CTD | PMID:27477297 |
Gclm | Rat | thifluzamide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | thifluzamide results in increased expression of GCLM mRNA | CTD | PMID:33512557 |
Gclm | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GCLM mRNA and Thioacetamide results in increased expression of GCLM protein | CTD | PMID:10486302 more ... |
Gclm | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of GCLM mRNA | CTD | PMID:34492290 |
Gclm | Rat | thiram | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Thiram results in increased expression of GCLM mRNA | CTD | PMID:23999411 more ... |
Gclm | Rat | titanium dioxide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLM mRNA | CTD | PMID:29950665 |
Gclm | Rat | titanium dioxide | decreases methylation | ISO | Gclm (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of GCLM gene | CTD | PMID:35295148 |
Gclm | Rat | toluene | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Toluene results in increased expression of GCLM mRNA | CTD | PMID:28245982 |
Gclm | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCLM mRNA | CTD | PMID:25729387 |
Gclm | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of GCLM mRNA | CTD | PMID:25729387 |
Gclm | Rat | trans-chalcone | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Chalcone analog results in increased expression of GCLM mRNA and Chalcone analog results in increased expression of GCLM protein | CTD | PMID:31299238 |
Gclm | Rat | trans-isoeugenol | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | isoeugenol results in increased expression of GCLM mRNA | CTD | PMID:20566472 more ... |
Gclm | Rat | triacsin C | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | triacsin C results in increased expression of GCLM mRNA | CTD | PMID:16704987 |
Gclm | Rat | tributylstannane | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | PRKCD gene mutant form promotes the reaction [tributyltin results in increased expression of GCLM mRNA] | CTD | PMID:25895139 |
Gclm | Rat | Tributyltin oxide | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of GCLM mRNA | CTD | PMID:26198647 |
Gclm | Rat | Tributyltin oxide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of GCLM mRNA | CTD | PMID:21601586 |
Gclm | Rat | Tributyltin oxide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of GCLM mRNA | CTD | PMID:21601586 |
Gclm | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of GCLM mRNA | CTD | PMID:19448997 and PMID:33387578 |
Gclm | Rat | trichostatin A | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | trichostatin A affects the expression of GCLM mRNA | CTD | PMID:28542535 |
Gclm | Rat | triclocarban | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [triclocarban co-treated with osteum] results in increased expression of GCLM mRNA | CTD | PMID:38631510 |
Gclm | Rat | trimethyltin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]] and rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA] | CTD | PMID:25895139 |
Gclm | Rat | trimethyltin | increases expression | ISO | Gclm (Mus musculus) | 6480464 | trimethyltin results in increased expression of GCLM mRNA | CTD | PMID:25895139 |
Gclm | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of GCLM mRNA | CTD | PMID:30589522 |
Gclm | Rat | triphenyl phosphate | affects expression | ISO | GCLM (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of GCLM mRNA | CTD | PMID:37042841 |
Gclm | Rat | tris(2-butoxyethyl) phosphate | decreases response to substance | ISO | Gclm (Mus musculus) | 6480464 | GCLM protein results in decreased susceptibility to tris(2-butoxyethyl) phosphate | CTD | PMID:25797475 |
Gclm | Rat | Tungsten carbide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of GCLM mRNA | CTD | PMID:23052192 |
Gclm | Rat | tunicamycin | decreases expression | ISO | Gclm (Mus musculus) | 6480464 | Tunicamycin results in decreased expression of GCLM mRNA | CTD | PMID:17127020 |
Gclm | Rat | tunicamycin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of GCLM mRNA | CTD | PMID:36586010 |
Gclm | Rat | tunicamycin | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of GCLM mRNA | CTD | PMID:29453283 |
Gclm | Rat | undecanal | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | undecanal analog results in increased expression of GCLM mRNA | CTD | PMID:27965148 |
Gclm | Rat | ursodeoxycholic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLM mRNA] and Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLM mRNA] | CTD | PMID:19073151 |
Gclm | Rat | ursodeoxycholic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Ursodeoxycholic Acid results in increased expression of GCLM mRNA | CTD | PMID:19073151 |
Gclm | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of GCLM mRNA | CTD | PMID:24136188 |
Gclm | Rat | valproic acid | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA | CTD | PMID:27188386 |
Gclm | Rat | valproic acid | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GCLM mRNA | CTD | PMID:23179753 more ... |
Gclm | Rat | vancomycin | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein] | CTD | PMID:36535435 |
Gclm | Rat | vanillin | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | vanillin results in increased expression of GCLM mRNA | CTD | PMID:17178418 |
Gclm | Rat | vincristine | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine | CTD | PMID:10900222 |
Gclm | Rat | vincristine | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Vincristine results in decreased expression of GCLM mRNA | CTD | PMID:23649840 |
Gclm | Rat | vitamin D | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Vitamin D results in increased expression of GCLM mRNA | CTD | PMID:30698894 |
Gclm | Rat | vitamin D | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Particulate Matter co-treated with Vitamin D] results in increased expression of GCLM mRNA and [Silicon Dioxide co-treated with Vitamin D] results in increased expression of GCLM mRNA | CTD | PMID:30698894 |
Gclm | Rat | vitamin E | multiple interactions | EXP | | 6480464 | Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] | CTD | PMID:16298738 |
Gclm | Rat | vitamin E | affects expression | EXP | | 6480464 | Vitamin E affects the expression of GCLM mRNA | CTD | PMID:16298738 and PMID:20447326 |
Gclm | Rat | wortmannin | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | Wortmannin inhibits the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of GCLM mRNA]] | CTD | PMID:34077701 |
Gclm | Rat | XAV939 | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mRNA | CTD | PMID:34480604 |
Gclm | Rat | zinc acetate | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Zinc Acetate results in increased expression of GCLM mRNA | CTD | PMID:16357179 |
Gclm | Rat | zinc acetate | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GCLM mRNA | CTD | PMID:16357179 |
Gclm | Rat | zinc atom | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of GCLM mRNA and Zinc deficiency results in decreased expression of GCLM protein | CTD | PMID:23377617 |
Gclm | Rat | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of GCLM mRNA and Zinc deficiency results in decreased expression of GCLM protein | CTD | PMID:23377617 |
Gclm | Rat | zinc dichloride | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA] | CTD | PMID:18385089 |
Gclm | Rat | zinc oxide | multiple interactions | ISO | Gclm (Mus musculus) | 6480464 | [Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein] more ... | CTD | PMID:30500950 more ... |
Gclm | Rat | zinc oxide | increases expression | ISO | Gclm (Mus musculus) | 6480464 | Zinc Oxide analog results in increased expression of GCLM mRNA and Zinc Oxide analog results in increased expression of GCLM protein | CTD | PMID:35247504 more ... |
Gclm | Rat | zinc oxide | multiple interactions | ISO | GCLM (Homo sapiens) | 6480464 | RU.521 inhibits the reaction [Zinc Oxide analog results in increased expression of GCLM protein] | CTD | PMID:36368621 |
Gclm | Rat | zinc oxide | increases expression | ISO | GCLM (Homo sapiens) | 6480464 | Zinc Oxide analog results in increased expression of GCLM protein | CTD | PMID:36368621 |
Gclm | Rat | zinc(0) | decreases expression | ISO | GCLM (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of GCLM mRNA and Zinc deficiency results in decreased expression of GCLM protein | CTD | PMID:23377617 |
Gclm | Rat | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of GCLM mRNA and Zinc deficiency results in decreased expression of GCLM protein | CTD | PMID:23377617 |